Anlon Healthcare Ltd.
Fundamentals
- Market cap
- ₹866 cr
- P/E
- 31.14×
- ROE
- 25.51%
- Debt / equity
- 0.83
- 52-week range
- 9.08 — 17.27
Company snapshot
Anlon Healthcare Ltd.
Pharmaceuticals
₹837 cr
P/E 30.10×
Latest quarter · Mar 2026
Sales₹51 cr
Net profit₹11 cr
Op. margin+30.1%
EPS₹0.20
Strength & growth
Debt / equity0.83×
Current ratio2.64×
The timeline — 3 notes on Anlon Healthcare Ltd.
June 2026
- 09 Jun 26 · 11:24 AM IST Brief Brief · Earnings · Micro cap
Anlon Healthcare plans ₹130 cr Rajkot build to back FY28 revenue target
The micro-cap is adding organic capacity after two acquisitions. A half-debt funding plan and early-stage M&A talks frame the next leg of growth.
- 03 Jun 26 · 5:29 PM IST Brief Brief · Concalls · Micro cap
Anlon's Rajkot capex balloons to ₹130 cr; ₹28 cr distributor default disclosed
The contract drugmaker quadrupled its planned spending on a new facility, taking on ₹65-70 crore in debt, and revealed a large receivables default only when pressed in the Q&A.